220 related articles for article (PubMed ID: 32458230)
1. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.
Fox ER; Stolbach AI; Mazer-Amirshahi M
J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230
[No Abstract] [Full Text] [Related]
2. ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic.
Mazer-Amirshahi M; Fox ER; Farmer BM; Stolbach AI
J Med Toxicol; 2020 Jul; 16(3):346-348. PubMed ID: 32418120
[No Abstract] [Full Text] [Related]
3. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
Madhusoodanan J
Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
[No Abstract] [Full Text] [Related]
4. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
Lu J; Liu X
Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
[No Abstract] [Full Text] [Related]
5. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
6. How to Discover Antiviral Drugs Quickly.
Parks JM; Smith JC
N Engl J Med; 2020 Jun; 382(23):2261-2264. PubMed ID: 32433861
[No Abstract] [Full Text] [Related]
7. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
8. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
9. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?
Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472
[No Abstract] [Full Text] [Related]
10. COVID-19: Stay Cool toward Corticosteroids.
Fujishima S
Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
[No Abstract] [Full Text] [Related]
11. Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).
Liew Y; Lee WHL; Tan L; Kwa ALH; Thien SY; Cherng BPZ; Chung SJ
Int J Antimicrob Agents; 2020 Nov; 56(5):106145. PubMed ID: 32860880
[TBL] [Abstract][Full Text] [Related]
12. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
13. Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
[No Abstract] [Full Text] [Related]
14. Chloroquine and COVID-19, where do we stand?
Lecuit M
Med Mal Infect; 2020 May; 50(3):229-230. PubMed ID: 32217166
[No Abstract] [Full Text] [Related]
15. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
16. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
17. Cationic drugs and COVID-19.
Brenna OV; Torretta S; Pignataro L; Di Berardino F
Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
Abbasi J
JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
[No Abstract] [Full Text] [Related]
19. Ensuring Access to Medications in the US During the COVID-19 Pandemic.
Alexander GC; Qato DM
JAMA; 2020 Jul; 324(1):31-32. PubMed ID: 32271871
[No Abstract] [Full Text] [Related]
20. A Call for Pediatric COVID-19 Clinical Trials.
Campbell JI; Ocwieja KE; Nakamura MM
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32398330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
